台灣微創醫療器材股份有限公司 Approved
最後更新時間 2025/07/18 , 07:14 AM
最後更新時間 2025/07/18 , 07:14 AM
負責人
Liang,Huang-Qian
統一編號
25098389
成立日期
2009/12/29
資本額
NT$500,000,000
實收資本額
NT$391,836,300
股票代號
6767
電話
03-5828999
地址
1F, No. 26, Sec. 2, Shengyi Rd., Zhubei City, Hsinchu County, 302, Taiwan
董監事
姓名 職稱 持有股份 代表法人
Liang,Huang-Qian Chairman 5.96%
Dai,Yuan-Wei Director 0.00%
Su,Yi-Jun Director 5.03%
Lin,Jun-Nan Director 29.87% INTAI TECHNOLOGY CORP.
Wang,Jin-Xiang Director 29.87% INTAI TECHNOLOGY CORP.
Liu,Tian-Ren Independent Director 0.00%
Ke,Ren-Wei Independent Director 0.00%
Chen,Wei-Zhi Independent Director 0.00%
Jiang,Hui-Xian Independent Director 0.00%
營業項目
  • Manufacture of Other Medical Instruments and Supplies(332900)
  • Manufacture of Other Optical Instruments and Equipment(277999)
  • Wholesale of Other Machinery and Equipment(464915)
  • Other Professional, Scientific and Technical Activities Not Elsewhere Classified(760999)
  • 公司歷程
  • Change Capital to 500,000,000
    2019/01/19
  • Change Person in Charge to Liang,Huang-Qian
    2016/07/18
  • Change Capital to 300,000,000
    2013/12/24
  • Change Person in Charge to Lin,Bao-Zhang
    2013/05/09
  • Change Person in Charge to Liang,Huang-Qian
    2011/08/26
  • 員工人數
    下載完整報告查看完整數據
    財務報表
    項目 2025 2024 2023
    Operating income 81,706 334,730 282,538
    Operating cost 17,209 70,962 59,940
    Profit (loss) of initial recognition of biological asset and agricultural products - - -
    Profit (loss) on changes in fair value less costs to sell of biological asset for current period - - -
    Operating gross profit (loss) 64,497 263,768 222,598
    Unrealized profit (loss) on sales of goods - - -
    Realized profit (loss) on sales of goods - - -
    Operating gross profit (loss), net 64,497 263,768 222,598
    Operating expenses 61,614 312,130 241,001
    Other gain (loss), net - - -
    Operating profit (loss) 2,883 -48,362 -18,403
    Non-operating income and expenses 2,267 -656 20,006
    Net profit (loss) before tax 5,150 -49,018 1,603
    Income tax expense (benefits) - 28 117
    Net profit (loss) of ongoing business for the current period 5,150 -49,046 1,486
    Profit (loss) of closed units - - -
    Profit (loss) of non-jointly controlled equity before merger - - -
    Net profit (loss) for the current period 5,150 -49,046 1,486
    Other comprehensive profit (loss), net 39 194 -20
    Comprehensive net profit and loss of non-jointly controlled equity before merger - - -
    Total comprehensive profit and loss for the current period 5,189 -48,852 1,466
    Net profit (loss) attributable to owners of parent company 5,150 -49,046 1,486
    Net profit (loss) form equity attributable to former owner of business combination under common control - - -
    Net profit (loss) attributable to non-controlling interests - - -
    Comprehensive profit (loss) attributable to owners of parent company 5,189 -48,852 1,466
    Comprehensive profit (loss) form equity attributable to former owner of business combination under common control - - -
    Comprehensive profit (loss) attributable to non-controlling interests - - -
    Basic earnings per share (yuan) 0 -1 0
    項目 2025 2024 2023
    Net cash inflow (outflow) from operating activities -11,608 -26,976 -15,457
    Net cash inflows (outflows) from investing activities -2,106 -169,991 -914
    Net cash inflow (outflow) from financing activities 351 254,647 -8,376
    Effect of Exchange Rate Changes on Cash and Cash Equivalents 10 159 -34
    Increase (decrease) in cash and cash equivalents in the current period -13,353 57,839 -24,781
    Beginning balance of cash and cash equivalents 101,932 44,093 68,874
    Ending balance of cash and cash equivalents 88,579 101,932 44,093
    項目 2025 2024 2023
    Current asset 505,428 519,482 279,519
    Non-current asset 215,078 212,893 217,985
    Total asset 720,506 732,375 497,504
    Current liability 42,078 73,816 56,335
    Non-current liability 81,277 66,597 70,355
    Total liability 123,355 140,413 126,690
    share capital 391,836 391,836 291,090
    Equity - secruity token - - -
    capital reserve 325,191 325,191 155,937
    retained earning -120,108 -125,258 -76,212
    Other equity 232 193 -1
    Treasury stock - - -
    Total equity attributable to owners of parent company 597,151 591,962 370,814
    Equity attributable to former owner of business combination under common control - - -
    Equity attributable to non-controlling interest before business merger under common control - - -
    Non-controlling interests - - -
    Total Equity 597,151 591,962 370,814
    Share capital awaiting retirement (unit: share) - - -
    Issued shares of advance equity (unit: shares) 0 0 0
    Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) 0 0 0
    Net asset value per share 15 15 12
    動產抵押
    下載完整報告查看完整數據
    案件類別 債務人名稱 債務人統編 契約啟始日期 契約終止日期 抵押權人名稱 抵押權人統編 擔保債權金額
    選舉收入(政治獻金)
    收入名稱 收入金額
    總收入金額
    選舉支出(政治獻金)
    支出名稱 支出金額
    總支出金額
    標案拒往
    機關名稱 生效日期 截止日期
    進出口資料
    下載完整報告查看完整數據
    年份 月份 總進口實績(美金) 總出口實績(美金)
    商標
  • Osteocera
  • Bicera
  • 脊固立
  • 台微醫
  • wiltrom
  • 台微醫喜瑞骨
  • 台微醫康骨益
  • 喜瑞骨
  • 康骨益
  • Wiltrom
  • 專利
    政府標案
    標案名稱 機關名稱 決標日期 決標金額 是否得標
    裁判書查詢
    勞權違規
    日期 違反法規法條 罰鍰金額
    污染源裁處
    污染類別 裁處時間 裁處機關 裁處金額 違反事實 違反法令 裁處書字號 裁處理由及法令 公司地址
    本頁內所載之資料,所載資料之完整性、即時性和正確性仍應以資料來源單位為準。
    公司一有新動態,我們馬上通知你,追蹤公司讓你不錯過任何更新。